Interleukin-2 inhibits growth of fibroblasts derived from human bone marrow

Acta Haematol. 1990;83(1):26-30. doi: 10.1159/000205158.

Abstract

The adherent layer that forms in human bone marrow suspension cultures contains fibroblast colonies which arise from colony-forming cells (CFU-F). We have demonstrated that recombinant interleukin-2 (r-IL2) inhibits growth of CFU-F by preventing their entry into S phase. This inhibition is not mediated by gamma-interferon, nor by T lymphocytes, and can be abrogated by anti-IL2 receptor antibody. r-IL2 may influence haematopoiesis by its effect on bone marrow CFU-F.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Factors / pharmacology
  • Bone Marrow / drug effects*
  • Bone Marrow Cells
  • Cell Adhesion / drug effects
  • Cell Division / drug effects
  • Cells, Cultured / cytology
  • Cells, Cultured / drug effects
  • Colony-Forming Units Assay
  • Cytokines
  • Depression, Chemical
  • Dose-Response Relationship, Drug
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Humans
  • Interleukin-2 / pharmacology*
  • Recombinant Proteins / pharmacology

Substances

  • Biological Factors
  • Cytokines
  • Interleukin-2
  • Recombinant Proteins